Medical Health & Life Science Research News

Research delivers insight into the bladder cancer therapeutics market

Asia-Pacific Bladder Cancer Therapeutics market is expected to reach USD 106.6 million by 2021 from USD 80.8 million in 2016, growing at a CAGR of 5.68% during forecast period 2016-2021.

- Advertising -

Bladder cancer is aroused due to malignancy of urinary bladder lining with epithelial cells. Bladder is an organ present at lower part of abdomen and stores urine.

Over developing of these epithelial cells results in blabber cancer and it can be of many types such as transitional cell carcinoma, squamous cell carcinoma, and adenocarcinoma. At present number of therapies have been evolved for the management of bladder cancers include chemotherapies, immunotherapies, surgeries, radiation therapies, and other therapies.

- Advertising -

Browse market data tables and in-depth TOC of the Asia-Pacific Bladder Cancer Therapeutics market  to 2021 at…tics-market-1152/

Rising healthcare expenditure, increasing cancer patient population, growing involvement of universities & research institutes, and rising focus of foreign pharmaceutical companies on Asian market are driving the growth of bladder cancer therapeutics market in Asia-Pacific. However, unawareness among bladder cancer patients about advanced cancer therapies and presence of more number of generic bladder cancer therapeutics are constraining the growth of bladder cancer therapeutics market in Asia-Pacific.


Asia-Pacific Bladder Cancer Therapeutics market is segmented based on type and treatment. Based on type, the market is further sub-segmented as Transitional Cell Bladder Cancer, Non Muscle Invasive/Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Adenocarcinoma of the Bladder, and Rare Bladder Cancers.

Based on treatment, the market is further segmented as Surgery, Chemotherapy, Immunotherapy, Radiation Therapy, and Intravesical Therapy.


On the basis of geographical areas, Asia-Pacific Bladder Cancer Therapeutics market is segmented as Japan, China, India, South Korea, and Australia.

The key players in Bladder Cancer Therapeutics market include, Sanofi S.A. (France), Novartis AG (Switzerland), Pfizer Inc.

(U.S.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), AstraZeneca plc (U.K.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Celgene Corporation (U.S.).


News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...